HR. 3493In Committee
Global Fairness in Drug Pricing Act
Require drug manufacturers to report and respond to international prescription drug price differences as part of drug pricing fairness policy
Plain-English overview
What this bill does
Require drug manufacturers to report and respond to international prescription drug price differences as part of drug pricing fairness policy
Key points
- Require manufacturer price reporting
Current status
Where it stands
Status
In Committee
Latest action
2025-05-19 — Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Related context
Topics and policy areas
undefinedHealth